Final results of a Phase I/II dose escalation trial in non–small-cell lung cancer using three-dimensional conformal radiotherapy

Phase III Study of Concurrent Versus Sequential Thoracic Radiotherapy in Combination With Mitomycin, Vindesine, and Cisplatin in Unresectable Stage III Non–Small-Cell Lung Cancer

1999 • 1,501 citations

Effects of Concomitant Cisplatin and Radiotherapy on Inoperable Non-Small-Cell Lung Cancer

1992 • 1,287 citations

Calculation of complication probability factors for non-uniform normal tissue irradiation: The effective volume method gerald

1989 • 880 citations

Radiation pneumonitis as a function of mean lung dose: an analysis of pooled data of 540 patients

1998 • 745 citations

Continuous, hyperfractionated, accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small cell lung cancer: mature data from the randomised multicentre trial

1999 • 486 citations

High-dose radiation improved local tumor control and overall survival in patients with inoperable/unresectable non–small-cell lung cancer: Long-term results of a radiation dose escalation study

2005 • 482 citations

Toxicity and outcome results of RTOG 9311: A phase I–II dose-escalation study using three-dimensional conformal radiotherapy in patients with inoperable non–small-cell lung carcinoma

2005 • 445 citations

Concurrent versus sequential chemoradiotherapy with cisplatin and vinorelbine in locally advanced non-small cell lung cancer: a randomized study

2004 • 414 citations

Radiotherapy Alone for Medically Inoperable Stage I Non-Small–Cell Lung Cancer: The Duke Experience

1998 • 347 citations

Dose Escalation in Non–Small-Cell Lung Cancer Using Three-Dimensional Conformal Radiation Therapy: Update of a Phase I Trial

2001 • 324 citations

Automatic three‐dimensional correlation of CT‐CT, CT‐MRI, and CT‐SPECT using chamfer matching

1994 • 255 citations

A new approach to dose escalation in non–small-cell lung cancer

2001 • 251 citations

Portal imaging to assess set-up errors, tumor motion and tumor shrinkage during conformal radiotherapy of non-small cell lung cancer

2003 • 242 citations

Selective mediastinal node irradiation based on FDG-PET scan data in patients with non–small-cell lung cancer: A prospective clinical study

2005 • 211 citations

High-dose conformal radiotherapy for treatment of stage IIIA/IIIB non-small-cell lung cancer: technical issues and results of a phase I/II trial

2002 • 205 citations

Dose, volume, and tumor control prediction in primary radiotherapy of non-small-cell lung cancer

2002 • 194 citations

Induction and Concurrent Chemotherapy With High-Dose Thoracic Conformal Radiation Therapy in Unresectable Stage IIIA and IIIB Non–Small-Cell Lung Cancer: A Dose-Escalation Phase I Trial

2004 • 152 citations

Evaluation of two dose–volume histogram reduction models for the prediction of radiation pneumonitis

1998 • 136 citations

First results of a phase I/II dose escalation trial in non-small cell lung cancer using three-dimensional conformal radiotherapy

2003 • 122 citations

Challenges in defining radiation pneumonitis in patients with lung cancer

2005 • 120 citations

The simultaneous boost technique: the concept of relative normalized total dose

1991 • 118 citations

Bronchial stenosis: An underreported complication of high-dose external beam radiotherapy for lung cancer?

2004 • 104 citations

Incorporating an improved dose-calculation algorithm in conformal radiotherapy of lung cancer: re-evaluation of dose in normal lung tissue

2003 • 95 citations

Effect of Radiotherapy and Chemotherapy on Pulmonary Function After Treatment for Breast Cancer and Lymphoma: A Follow-Up Study

1999 • 77 citations

Results following treatment to doses of 92.4 or 102.9 Gy on a phase I dose escalation study for non-small cell lung cancer

2003 • 72 citations

Escalated dose for non-small-cell lung cancer with accelerated hypofractionated three-dimensional conformal radiation therapy

2004 • 53 citations

Evaluation of isoeffect formulae for predicting radiation-induced lung damage

1993 • 50 citations

Endpoints for multimodal clinical trials in Stage III non-small cell lung cancer (NSCLC): a consensus report

1994 • 35 citations

A treatment planning method to correct dose distributions distorted by setup verification fields

2000 • 10 citations

Long-term complication risk after very high dose thoracic radiotherapy

2002 • 4 citations

Cited By (0)

Loading...